SCHEMBL22884378

SCHEMBL22884378

c1ccc(-c2ccc3c(c2)oc2ccc(-c4nc(-c5ccccc5)nc(-c5cc6c(cc5-c5ccccc5)oc5ccccc56)n4)cc23)cc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PLA2G2A P14555 3/20 0.43
▸ PLA2G4A P47712 3/20 0.43
▸ MMP12 P39900 2/20 0.40
▸ MMP13 P45452 1/20 0.40
▸ HCRTR1 O43613 1/20 0.39
▸ ALDH1A1 P00352 5/20 0.39
▸ MAPT P10636 4/20 0.39
▸ KDM4E B2RXH2 4/20 0.39
▸ HPGD P15428 4/20 0.39
▸ KMT2A Q03164 3/20 0.39
▸ AHR P35869 2/20 0.39
▸ MEN1 O00255 2/20 0.39
▸ NPC1 O15118 1/20 0.39
▸ RAB9A P51151 1/20 0.39
▸ SMN1; SMN2 Q16637 1/20 0.39
▸ PLA2G10 O15496 1/20 0.39
▸ CHEK2 O96017 1/20 0.38
▸ ALOX15 P16050 1/20 0.38
▸ TSHR P16473 1/20 0.38
▸ CASP1 P29466 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22884882 1.00 PLA2G2A (0.43) PLA2G2APLA2G4AMMP12MMP13HCRTR1
SCHEMBL22884400 0.97 PLA2G2A (0.45) PLA2G2APLA2G4AMMP12MMP13ALDH1A1
SCHEMBL23118297 0.97 MMP12 (0.42) PLA2G2APLA2G4AMMP12MMP13HCRTR1
SCHEMBL23823848 0.93 AHR (0.41) PLA2G2APLA2G4AMMP12MMP13HCRTR1
SCHEMBL25458156 0.93 PLA2G2A (0.43) PLA2G2APLA2G4AALDH1A1MAPTKDM4E
SCHEMBL24217313 0.93 PLA2G2A (0.48) PLA2G2APLA2G4AMMP12MMP13HCRTR1
SCHEMBL24525897 0.93 AHR (0.44) PLA2G2APLA2G4AALDH1A1MAPTKDM4E
SCHEMBL24215932 0.93 PLA2G2A (0.48) PLA2G2APLA2G4AMMP12MMP13HCRTR1
SCHEMBL23913802 0.93 PLA2G2A (0.48) PLA2G2APLA2G4AMMP12MMP13HCRTR1
SCHEMBL25458925 0.93 PLA2G2A (0.48) PLA2G2APLA2G4AMMP12MMP13HCRTR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3763720-B1 COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING SAME LG CHEMICAL LTD (KR) 2023-11-22 — — EP disclosed
US-20210083198-A1 COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING SAME LG CHEM, LTD. 2021-03-18 — — US disclosed
EP-3763720-A1 COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING SAME LG CHEM, LTD. (KR) 2021-01-13 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210083198-A1 COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING SAME CRY1, CYP1A1, CRY2 PLA2G2A 4159/4885PLA2G4A 4198/4885MMP12 4065/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback